DE2542255A1 - Mittel zur intravaskulaeren verabreichung - Google Patents

Mittel zur intravaskulaeren verabreichung

Info

Publication number
DE2542255A1
DE2542255A1 DE19752542255 DE2542255A DE2542255A1 DE 2542255 A1 DE2542255 A1 DE 2542255A1 DE 19752542255 DE19752542255 DE 19752542255 DE 2542255 A DE2542255 A DE 2542255A DE 2542255 A1 DE2542255 A1 DE 2542255A1
Authority
DE
Germany
Prior art keywords
particles
groups
water
bound
radionuclide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752542255
Other languages
German (de)
English (en)
Inventor
Sven Lennart Kaagedal
Ulf Sven Erik Rothman
John Lennart Soederberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Pharmacia Fine Chemicals AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Fine Chemicals AB filed Critical Pharmacia Fine Chemicals AB
Publication of DE2542255A1 publication Critical patent/DE2542255A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1213—Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752542255 1974-09-27 1975-09-23 Mittel zur intravaskulaeren verabreichung Pending DE2542255A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7412164A SE7412164L (sv) 1974-09-27 1974-09-27 Medel for intravaskuler administrering

Publications (1)

Publication Number Publication Date
DE2542255A1 true DE2542255A1 (de) 1976-04-08

Family

ID=20322239

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752542255 Pending DE2542255A1 (de) 1974-09-27 1975-09-23 Mittel zur intravaskulaeren verabreichung

Country Status (6)

Country Link
US (1) US4115536A (https=)
JP (1) JPS5161620A (https=)
DE (1) DE2542255A1 (https=)
FR (1) FR2285857A1 (https=)
GB (1) GB1525860A (https=)
SE (1) SE7412164L (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666697A (en) * 1982-12-08 1987-05-19 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic agent

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303636A (en) * 1974-08-20 1981-12-01 Gordon Robert T Cancer treatment
US4243652A (en) * 1978-07-14 1981-01-06 The Procter & Gamble Company Gastrointestinal scanning agent
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
GB8422876D0 (en) * 1984-09-11 1984-10-17 Secr Defence Silicon implant devices
JPS62236839A (ja) * 1986-04-08 1987-10-16 Yoshiaki Motozato 架橋されたグルコマンナン球状粒子及びその製法
GB9000705D0 (en) * 1990-01-12 1990-03-14 Royal Postgrad Med School Improvements in or relating to radiotherapeutic agents
DE69638321D1 (de) * 1995-10-11 2011-03-03 Luminex Corp Gleichzeitige mehrfachanalyse klinischer proben
US6449562B1 (en) 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US6261320B1 (en) 1996-11-21 2001-07-17 Radiance Medical Systems, Inc. Radioactive vascular liner
US6458069B1 (en) 1998-02-19 2002-10-01 Endology, Inc. Multi layer radiation delivery balloon
US5782742A (en) 1997-01-31 1998-07-21 Cardiovascular Dynamics, Inc. Radiation delivery balloon
US6491619B1 (en) 1997-01-31 2002-12-10 Endologix, Inc Radiation delivery catheters and dosimetry methods
US5993374A (en) * 1997-06-17 1999-11-30 Radiance Medical Systems, Inc. Microcapsules for site-specific delivery
US6048299A (en) * 1997-11-07 2000-04-11 Radiance Medical Systems, Inc. Radiation delivery catheter
US6149574A (en) * 1997-12-19 2000-11-21 Radiance Medical Systems, Inc. Dual catheter radiation delivery system
EP1056515A1 (en) 1998-02-19 2000-12-06 Radiance Medical Systems Inc. Radioactive stent
FR2797769B1 (fr) * 1999-09-01 2003-07-25 Cis Bio Int Produits radiopharmaceutiques et leur procede de preparation
AUPR098300A0 (en) * 2000-10-25 2000-11-16 Sirtex Medical Limited Polymer based radionuclide containing microspheres
US8148171B2 (en) 2001-10-09 2012-04-03 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US20050164261A1 (en) * 2001-10-09 2005-07-28 Chandler Don J. Multiplexed analysis of clinical specimens apparatus and methods
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
FR2919189A1 (fr) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663685A (en) * 1968-04-01 1972-05-16 Minnesota Mining & Mfg Biodegradable radioactive particles
US3758678A (en) * 1968-09-26 1973-09-11 Minnesota Mining & Mfg Biodegradable radioactive polysaccharide particles
US3853987A (en) * 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666697A (en) * 1982-12-08 1987-05-19 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic agent

Also Published As

Publication number Publication date
SE7412164L (sv) 1976-03-29
US4115536A (en) 1978-09-19
FR2285857B1 (https=) 1979-09-14
JPS5161620A (https=) 1976-05-28
FR2285857A1 (fr) 1976-04-23
GB1525860A (en) 1978-09-20

Similar Documents

Publication Publication Date Title
DE2542255A1 (de) Mittel zur intravaskulaeren verabreichung
DE2646854C2 (https=)
DE69231935T2 (de) Konjugat enthaltend ein geradkettiges organisches polymer mit gebundenen sulfatierten glukosaminoglukanen wie zum beispiel heparin, seine herstellung, verwendung und ein entsprechendes substrat
DE2524279C2 (https=)
DE60116137T2 (de) Derivatisierung von proteinen in wässrigem lösungsmittel
DE3240174C2 (https=)
DE1720955C3 (de) Verfahren zur Herstellung eine polymeren Formgegenstands mit gegenüber Proteinen reaktiongsfähigen Gruppen auf seiner Oberfläche
DE69613569T2 (de) Biologisch abbaubare polyacetal-polymere, herstellung und anwendung
DE2005408C3 (de) Verfahren zur Herstellung von Ionenaustauschern und danach hergestellte Ionenaustauscher
DE69020276T2 (de) Amylose-Lysozym-Hybrid, ein Aktivzucker und Verfahren zur Herstellung.
CH413811A (de) Verfahren zur Herstellung von hydrophilen Erzeugnissen von hohem Molekulargewicht aus Dextransubstanzen
DE3434104A1 (de) Wasserunloesliche zubereitung von hyaluronsaeure und verfahren dazu
DE2844956A1 (de) In wasser quellbares teilchenfoermiges absorptionsmaterial und verfahren zu seiner herstellung
DE69925757T2 (de) Dextran-maleinsäuremonoester und hydrogele daraus
WO2004037865A1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
DE3150318A1 (de) "verfahren zur herstellung eines polysaccharidderivats des fibrinolysins"
DE69030553T2 (de) Verfahren zur Herstellung modifizierter Superoxid-Dismutase
DE2059165A1 (de) Streptokinase in chemischer Bindung an eine Kohlehydratverbindung
WO2002000229A1 (de) Verfahren zur herstellung künstlicher sauerstoffträger aus kovalent vernetzten hämoglobinen mit verbesserten funktionellen eigenschaften durch vernetzung in anwesenheit chemisch nicht reagierender effektoren der sauerstoffaffinität der hämoglobine
EP0593590B1 (de) Pharmazeutische zusammensetzung für die peritonealdialyse
DE2346774A1 (de) Roentgenkontrastmittel
EP0147369A2 (de) Ionisch modifiziertes Cellulosematerial, dessen Herstellung und Verwendung
DE3434082A1 (de) Wasserunloesliche zubereitung von hyaluronsaeure
DE3543942A1 (de) Hydrogele mit roentgenkontrast, ihre herstellung und ihre verwendung
DE2501840C3 (de) Verfahren zur Unlöslichmachung eines Enzyms

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee